Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
GLP-1 production increases feeling of satiety by: slowing gastric emptying feel fuller, faster & longer suppressing appetite receptors in brain less hunger & cravings GLP-1 cells in the small intestine regulate carbohydrate metabolism through: increasing insulin production regulates blood glucose suppressing glucagon release Ideal Candidates GLP-1 medications have been successfully used for obese patients (BMI greater than or equal to 30) and for overweight patients (BMI greater than or equal to 27) who also have other health conditions contributing to weight
De Souza, J
Compounded medications aren't FDA-approved products
From a public health perspective, the short-term cost of boosting GLP-1 drug coverage could lead to long-term cost savings associated with emergent and routine care for chronic conditions like cardiovascular disease, liver disease, heart failure, and depression, all of which are comorbid with obesity
